TABLE 2.
CTL responses following challengea
| Vaccination and monkey | Tetramer binding
|
Functional cytotoxicity (stimulated PBMC) | |
|---|---|---|---|
| Fresh PBMC | Stimulated PBMC | ||
| Control MVA | |||
| H544 | 0.1 | 2 | 2 |
| H547 | 0.1 | 1 | 0 |
| H549 | 0.7 | 19 | 22 |
| H561 | 1.7 | 8 | 11 |
| Recombinant MVA | |||
| T119 | 7.5 | 48 | 29 |
| H500 | 3.9 | 49 | 37 |
| H507 | 13.5 | 59 | 34 |
| H511 | 2.5 | 42 | 28 |
SIV Gag p11C-specific CD8+ T-cell responses as measured by tetramer staining of freshly isolated and peptide-stimulated PBMC and chromium release functional cytotoxicity assays at day 17 after challenge. The percent CD3+ CD8+ cells that bind tetramer is shown for the tetramer assays. The percent specific lysis at a 5:1 effector-to-target ratio is shown for the cytotoxicity assays.